Работы, цитирующие эту работу

Работ: 2

Работа: Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

1. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity

   Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani +11

   СтатьяChemotherapy-induced cardiotoxicity and mitigationInnovative medicine of Kuban2023Цитирований: 1

   ABIABI:AkademIndex/openalex/2023.article.001614

2. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)

   Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15

   СтатьяDiabetes Treatment and ManagementInnovative medicine of Kuban2024Цитирований: 1

   ABIABI:AkademIndex/openalex/2024.article.001048